Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.

[1]  S. Grundy.  Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. , 1986, The New England journal of medicine.

[2]  R. Gregg,et al.  An approach to the management of hyperlipoproteinemia. , 1986, JAMA.

[3]  J. Hupp.  Lowering Blood Cholesterol to Prevent Heart Disease , 1985, International Journal of Technology Assessment in Health Care.

[4]  W. Harris,et al.  Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia , 1985 .

[5]  S. Grundy,et al.  Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. , 1985, Journal of lipid research.

[6]  Roger A. Renfrew,et al.  Lipid Research Clinics Program. , 1984, JAMA.

[7]  R. Havel,et al.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Grundy,et al.  Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides. , 1982, Metabolism: clinical and experimental.

[9]  A. Kissebah,et al.  Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. , 1981, Metabolism: clinical and experimental.

[10]  D. Bilheimer,et al.  Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Packard,et al.  Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit. , 1980, The Journal of biological chemistry.

[12]  H. G. Morgan,et al.  Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. , 1980, The New England journal of medicine.

[13]  S. Grundy,et al.  Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. , 1975, The Journal of clinical investigation.

[14]  P. Nestel,et al.  Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man. , 1973, The Journal of laboratory and clinical medicine.

[15]  A. Gotto,et al.  Cholestyramine in type II hyperlipoproteinemia. A double-blind trial. , 1973, Annals of internal medicine.

[16]  D. Porte,et al.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. , 1973, The Journal of clinical investigation.

[17]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[18]  S. Grundy,et al.  Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. , 1971, The Journal of laboratory and clinical medicine.

[19]  J. Farquhar,et al.  Carbohydrate-induced and fat-induced lipemia. , 1961, Transactions of the Association of American Physicians.